講演者

Niklas Engler

Global Head and Vice President, Technical Development Portfolio and Projects

F. Hoffmann-La Roche

Thomas Seewoester

Vice President, Site Operations

Amgen

James Warren

VP Pharmceutical Development

Ultragenyx

Tracy Ryan

Co-Founder & Chief Communications Officer

NKore BioTherapeutics

Fouad Atouf

Vice President, Science-Global Biologics

US Pharmacopeia

Kartik Subramanian, Ph.D.

Vice President, Biologics Product Development, Science and Technology

AbbVie

Colette Ranucci

Vice President, Global Large Molecules, Technical Operations

Merck

Nick Alden

Associate Director, Analytical Development Automation

Ultragenyx Pharmaceutical

Rosalind Ang

Associate Principal Scientist - Biologics & Analytical Research & Development

Merck (pending final confirmation)

Efecan Aral

Postdoctoral Associate, Cell Science and Technology

Sanofi

Andrei Arion

Associate Scientist, Cell Line and Upstream Process Development

Alexion, AstraZeneca Rare Disease

Regina Au

CEO, New Product Planning/Strategic Planning

BioMarketing Insight

Engin Ayturk

Senior Director, CMC BioConjugation, Process Development & Manufacturing

Exelixis

Jordan Ball

Sr. Manager, Technology Transfer

Regeneron

A Representative from Biophorum

-

BioPhorum

James Blackwell

President and Principal Consultant

The Windshire Group, LLC

Mark Blenner

Associate Professor

University of Delaware

Mr Rajeev Boregowda

Associate Director, Bioassay & Molecular Analytical Development, Genomic Medicine CMC

Sanofi

Mahesh Bule

Associate Director

Kite Pharma a Gilead Company

Daniel Burke

Senior Scientist

Merck

Michael Butler

Principal Investigator, Cell Technology

NIBRT

Ying Cai

MSAT Executive Director

Ultragenyx Pharmaceutical

Brenda Carillo-Conde

Group Leader

Pfizer

Wolfram Carius, PhD

Executive Vice President, Pharmaceuticals, Cell and Gene Therapy

Bayer Pharmaceuticals

Lina Chakrabarti

Associate Director, R & D

Astrazeneca

Callum Chapman

Senior Director,  Product Quality

AstraZeneca

Thomas Chattaway

Senior Life Science Consultant

Independent

Jeron Chen

Head of Data Science and Payload Innovation

Voyager Therapeutics

Wei-Chiang Chen

Associate Director, BioProcess Analytics, Genomic Medicine Unit

Sanofi

Emma Cooper

Process Development Engineer

Regeneron

Kabir Dhingra

Senior Scientist

Merck

Yanhuai Ding

Sr . Director, CMC DS/DP

Evolve Immune Therapeutics

David Dobnik

Scientific Associate

National Institute of Biology

Mark Duerkop

Chief Executive Officer

Novasign, Austria

Mark Farmery

Chief Development Officer

Anocca AB

Aaron Fisher

Director, Life Sciences Investments

ARCHIMED

Daniel Friedman

Principal

BroadOak Capital

A Representative from Sanofi

,

Sanofi

Coral Fung Shek

Process Development Associate Scientist

Amgen

Shireen Goh

Associate Professor

Singapore University of Technology & Design (SUTD)

Jack Greene

Chief Technical and Manufacturing Officer

JucaBio

Jongyoon Han, Ph.D.

Professor, PI of the Micro-Nanofluidic BioMEMS group at RLE

Massachusetts Institute of Technology

Yuxin He

Sr Engineer II

Moderna

Chase Herman, Ph.D.

Investigator

GSK

Christoph Herwig

Senior Scientific Advisor

Körber Pharma Austria GmbH, Austria

Margit Holzer, Ph.D.

Scientific Director

Ulysse Consult S.a.r.L

Dr Wei Huang

President

Henlius Biopharmaceutical Ltd, China

David Humphreys, PhD

Executive Director and Head of Antibody and Novel Therapeutics

UCB Pharma

Christopher Hwang

Chief Technology Officer

Transcenta Holdings

Reagan Jarvis

Chief Executive Officer and Co-founder

Anocca

Hana Jug

Product Manager (Enveloped viruses, VLPs and EVs)

Sartorisu BIA Separations

Stephen Kennedy

Head of Technical Operations

CRISPR Therapeutics

Anis Khimani, PhD

Senior Strategy Leader

Revvity Inc

Erin Kimbrel

President & Head

Astellas Institute for Regenerative Medicine

Kat Kozyrytska

Managing Director

Kozyrytska Consulting

Elisabeth Krug

Executive Director, BRD Analytical Development

Eli Lilly & Company

Parag Kumthekar

Gene Therapy Downstream Process Development Lead

UCB Pharma

Kimberly Larson

Principal Scientist

Boehringer Ingelheim

Kelvin Lau

Principal Engineer

Abbvie

Kelvin Lee

Institute Director

NIIMBL

Jaeweon Lee, Ph.D

Student

University of Massachusetts Lowell

Marcus Lehmann

Associate Director, Drug Product Process Development

Satellite Bio

Abraham Lenhoff

Allan P. Colburn Professor

University of Delaware

Seth Levy

Senior Director, Bioprocess Development

Modalis Therapeutics

Jun Li

Associate Director - Upstream Process Development: Gene Therapy

Ultragenyx Pharmaceutical

Weiyi Li

Senior Manager, LNP Formulation

Prime Medicine, Inc.

Yi Li

Process Development Scientist

Amgen, Inc.

Ana Di Lillo

Scientist

AstraZeneca

Yuxin Liu

Scientist, Cell Culture Platform

Sanofi

Yue Liu, PhD

CEO

Ab Studio Inc.

Jarrod Longcor

Chief Operating Officer

Cellectar Biosciences

Moira Lynch

Director, Innovation

Thermo Fisher Scientific

Junfen Ma

Head of Genomic Medicine Purification Process Development

Sanofi

Divyanshu Malhotra

Senior Scientist

Genmab

Victor Manuel Diaz Cortes

Research Director

OneChain Immunotherapeutics S.L.

Lynn Mao

Senior Scientist

AstraZeneca

Jeff Masten

Senior Vice President CMC

Secretome Therapeutics

Guy Matthews

Director - Market Development Single Use Technology

Fuji Film Irvine Scientific

Stefano Menegatti

Associate Professor

North Carolina State University

Sara Miller

Director, Advanced Therapies Commercial Technical Lead

FUJIFILM Diosynth Biotechnologies

Bhanu Chandra Mulukutla

Group Leader

Pfizer

Shashi Murthy, PhD

CTO and Co-Founder

Nanite Inc.

Olga Paley, Ph.D.

Director, Head of mAb-Derived Biologics Process Development

Takeda

Prasad Pathange

Senior Manager

Bayer U.S.

Tracy Payne

SVP Business Development, Principal Consultant Business Strategy & Operations

Windshire Group, LLC.  Labshire, LLC

Lorena Pena

Scientist

Bristol-Myers Squibb

Lorraine Peters

Associate Scientist

AstraZeneca

Christine Pham

Principal Scientist, Purification Process Development

Gilead

Bryan Poltilove

Strategic Advisor and Independent Board Director

Independent

Shashi Prajapati

Director, Cell & Gene Therapies Analytical Development

Vertex Pharmaceuticals

Matthew Provencal

Executive Director Gene Therapy BDS Manufacturing

Sarepta

Monica Raimo

Director, Product and Process Development

Glycostem Therapeutics

Mr Phillip Ramsey

Senior Vice President, Technical Operations

Sangamo Therapeutics

Sidharth Razdan

Senior Scientist

Pfizer

Hunter Reese

Scientist II

Asklepios Biopharmaceutical

A Representative from Eli Lilly

Upstream Department

Eli Lilly

Keshab Rijal

Principal Scientist

Amgen

Kate Rochlin

Chief Operating Officer

IN8bio

Ruth Salmon

VP, BMS Cell Therapy Research

Bristol Myers Squibb

Shruti Santhosh

Engineer II

Biogen

Nicole Santimauro

Senior Engineer, Manufacturing Science and Technology

Century Therapeutics, Inc.

Andreas Schaaf

CSO & Managing Director

Eleva GmbH

Dana Schreffler

Sr. Manager QC Viral Safety

Regeneron

Jacqualyn Schulman, Ph.D.

Scientist, Cell Line Development & ‘Omics Biologics Development

Bristol-Myers Squibb

Susan Sharfstein, PhD

Professor of Nanobioscience, College of Nanoscale Science and Engineering

SUNY Polytechnic Institute

Amy Shaw

Head of Process and Product Development

Takeda, USA

Edwin Shen

Principal Scientist

Pfizer

Jindou Shi

PhD Student

GSK Center for Optical Molecular Imaging, UIUC

Wonjong Si

Associate Director, Cell Therapy Platform Process

Bayer

Yingnan (Michael) Si

Scientist

Sanofi

Naveen Singh

Principal Scientist II, Process Development

Gilead

Nripen Singh

Head of Process Development, TRD CGT

Novartis

Justin Skoble

Vice President of Technical Development

Caribou Biosciences, Inc.

Fernanda Sobreira

Associate Principal Scientist

Merck

Zhiwei Song

Senior Principal Scientist

A*STAR

Dr. Anand Srinivasan

Vice President of Technology and Innovations, and Head of the Center for Innovations and Biodesign

BioBridge Global

Arvind Srivastava, Ph.D.

Senior Vice President

ThirdArcBio

Xiaodong Sun

Senior Scientist

Takeda

Shankar Swaminathan, PhD

Team Lead, Associate Director Drug Product Development

Astellas Institute for Regenerative Medicine

Ms Mariska ter Haak

Senior Director Analytical Development

IN8bio

Crystal Thomas

Process Engineer III

Sanofi

Sarah Thomas

Senior Vice President, Quality

REGENXBIO Inc.

Shawn (Xueyuan) Wang

Director, Process Development

Kite Pharma

Shu Wang

Principal Investigator

Incyte

Dhanuka Wasalathanthri, PhD

Senior Principal Scientist

Bristol Myers Squibb

Mr William Whitford

Founder

Oamaru BioSystems

Kristy Wood, PhD

SVP, Technical Operations

Intellia Therapeutics

Jianlin (Jim) Xu

Global Head of Cell Culture Platform

Sanofi

Yifeng Xu

Principal Scientist

Pfizer

Dong Xu, Ph.D.

Associate Director, Cell Therapy Analytical Development

TScan Therapeutics

Ms Huize Yan

Process Development Scientist

Spark Therapeutics

Lena Yang

Senior Scientist, Cell Therapy Analytical Development

Takeda

Shu Yang

Senior Scientist

Pfizer

Linda Yi

Associate Director, Analytical Development

Biogen

Gregory Zarbis-Papastoitsis, Ph.D

Chief Process and Manufacturing Officer

Ankyra

Hao Zhang

Sr. Principal Scientist

Amgen

Zhengqi Zhang

Senior Scientist

Merck

Kate Zhao

Scientist I, Upstream Process Development

Alexion, AstraZeneca Rare Disease

Yuxiang (Henry) Zhao

Senior Scientist

Bristol-Myers Squibb

Yuechen Zhu

Staff Development Scientist

Bayer